When the animals were challenged with TRAMP-PSA tumor cells, MCMV/PSAFL showed no increase in tumor-specific T cells and failed to slow tumor growth, while MCMV/PSA65-73 increased PSA-specific CD8 T cell responses within the host and subsequently slowed tumor growth. This evidence concerns the gene CD8A and neoplasm.